Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
Therapeutic Advances in Medical Oncology|August 28, 2020
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocolAntonio Avallone, Maria Carmela Piccirillo, Elena Di Gennaro, et al.
Frontiers in Nutrition|April 3, 2023
The impact of preoperative nutritional screening, ERAS protocol, and mini-invasive surgery in surgical oncology: A multi-institutional SEM analysis of patients with digestive cancerLaura Lorenzon, Riccardo Caccialanza, Valentina Casalone, et al.
Oncotarget|May 18, 2016
HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2Valli De Re, Mariangela De Zorzi, Laura Caggiari, et al.
Frontiers in Endocrinology|December 17, 2021
Structured Reporting of Computed Tomography in the Staging of Neuroendocrine Neoplasms: A Delphi Consensus ProposalVincenza Granata, Francesca Coppola, Roberta Grassi, et al.
Infectious Agents and Cancer|December 9, 2020
The clinical and translational research activities at the INT - IRCCS "Fondazione Pascale" cancer center (Naples, Italy) during the COVID-19 pandemicFranco M Buonaguro, Gerardo Botti, Paolo Antonio Ascierto, et al.
Oncology and Therapy|May 20, 2026
Role and Characteristic of Multidisciplinarity in Hepatocellular Carcinoma Management and Care Pathway Certification: Bottom-Up Approach of the MDT Project in ItalyGiuseppe Cabibbo, Caterina Cocuzza, Ciro Celsa, et al.
BMC Cancer|September 11, 2019
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocolAlessandro Ottaiano, Stefania Scala, Nicola Normanno, et al.
Therapeutic Advances in Medical Oncology|April 15, 2021
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocolAlessandro Ottaiano, Stefania Scala, Mariachiara Santorsola, et al.
Neoplasia (New York, N.Y.)|December 22, 2024
Clinical and genetic drivers of oligo-metastatic disease in colon cancerAlessandro Ottaiano, Mariachiara Santorsola, Roberto Sirica, et al.
BMC Cancer|February 10, 2016
A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)Antonio Avallone, Maria Carmela Piccirillo, Luigi Aloj, et al.
Pageof 25